Photo of Cristina Larrosa taken from LinkedIn
Jan 21, 2024, 07:44
Cristina Larrosa: We recently mapped anti-GD2 mAbs availability worldwide
Cristina Larrosa, Pediatric Oncologist at Sant Joan de Déu Barcelona Hospital, recently posted on LinkedIn:
“We recently mapped anti-GD2 mAbs availability worldwide in our publication “Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2”. AntiGD2 mAbs, the standard of care in high-risk neuroblastoma first-line treatment, are not available in the countries where most children with cancer live.”
Source: Cristina Larrosa/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46